Travoprost: A prostaglandin analogue for the treatment of glaucoma

Formulary

Volumn 44, Issue 11, 2009, Pages 322-328

  Brooks, Traci C ^a,b   Burlingame, Mark ^b   Burk, Muriel ^c   Tortorice, Kathy ^d   Dong, Diane ^c   Glassman, Peter A ^e   Lynch, Jennie A ^f   Good, Chester B ^g   Rickman, Holly S ^h   Claborn, Melanie ⁱ   Appleman, Duva ^j   Jones, William ^k   Shaverd, Lanita ^h  

^a WOMACK ARMY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VACO PBM Services/VA Center for Medication Safety   (United States)

^d BCPS   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f VA Healthcare Network Upstate New York   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

ⁱ UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k VACO PBM Services and Southwest Consolidated Mail Outpatient Pharmacy   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST; TRAVOPROST;

AGED; ALTERNATIVE MEDICINE; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; EPIPHORA; EYE PAIN; FEMALE; GLAUCOMA; HUMAN; HYPEREMIA; HYPERPIGMENTATION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OPHTHALMOLOGY; OPTOMETRY; PRURITUS; VISUAL DISORDER; VISUAL FIELD;

EID: 77952145007     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Quigley HA, Vitale S. Models of Open-Angle Glaucoma Prevalence and Incidence in the United States. Invest Ophthalmol Vis Sci. 1997;38:83-91.
2. Glaucoma Research Foundation, http://www.glaucoma.org/learn/glaucoma- facts.php. Accessed October 15, 2009.
3. Georgopoulos G, Andreanos D. Liokis N, et al. Risk factors in ocular hypertension. Eur J Ophthamol. 1997;7:357-363.
4. Hoyng PF, van Beek LM. Pharmacological therapy for glaucoma: a review. Drugs. 2000;59:411-434. Erratum in: Drugs. 2002;62:1314.
5. Parrish RK, Palmberg P, Sheu WP; XLT Study Group. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol. 2003;135:688-703.
6. VHA Pharmacy Benefits Management Strategic Healthcare Group and the Medial Advisory Panel. Drug Class Review: Ophthalmic Prostaglandin Analogs. June 2002. www.pbm.va.gov/reviews/ophthprostopthreview5.pdf. Accessed September 24, 2009.
7. Netland PA, Landry T, Sullivan EK, et al.; Travoprost Study Group. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol. 2001;132:472-484.
8. Kumar RS, Istiantoro VW, Hoh ST, et al. Efficacy and safety of a systematic switch from latanoprost to travoprost in patients with glaucoma. J Glaucoma. 2007;16:606-609.